instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

Bioprocessing Division Drives Sartorius AG's Wide Moat Rating; Shares Fairly Valued | Morningstar

Switching Costs and Bioprocessing Leadership Drive Sartorius Stedim Biotech's Wide Moat | Morningstar

Bio-Rad's Steady Business and Stake in Sartorius Driving Long-Term Value | Morningstar

jetMESSENGER® technology for lymphocytes

mRNA transfection in T-cells

Kepler Capital upgrades Sartorius (0NIR) to a Hold | Markets Insider

Boost your transfection success with these proven expert tips

Deutsche Bank upgrades Sartorius (0NIR) to a Buy | Markets Insider

Sartorius AG (SARTF) Q1 2025 Earnings Call Highlights: Strong Start with Robust Growth in ...

Sartorius (SARTF) Reports Robust Q1 2025 Growth, Boosts U.S. Peers

Sartorius AG Earnings: Better-Than-Expected Results, Confirming an End to Destocking | Morningstar

Sartorius Shares Jump After Earnings, Sales Top Views | Morningstar

Sartorius AG (SARTF) Reports Strong Q1 Growth and Financial Improvements

Sartorius Q1 Net Results Increase; Expects FY25 Sales Revenue Growth Of Around 6%

Strong start to the year: Sartorius achieves significant profitable growth in the first quarter (news with additional features) | Valuespectrum.com
Latest news
Show more
Bond Market News Today: Alphabet (GOOGL) Back to Corporate Bond Market

Morning Note: Dollar Climbs on Trade Winds; BTC Soars; ECB's Dovish Tone

Stock Market Today: Dow Jones Up, Nvidia stock fluctuates, Nasdaq Rises